Press release
Artificial Intelligence (AI) In Respiratory Diseases Market on Track for Strong Growth, Estimated to Grow at 5.2% CAGR Through 2029
Artificial Intelligence (AI) In Respiratory Diseases Market
What Is the Expected CAGR for the Artificial Intelligence (AI) In Respiratory Diseases Market Through 2025?
Recent years have witnessed robust growth in the market size of artificial intelligence (AI) in relation to respiratory diseases. The market size is projected to expand from $7.66 billion in 2024 to $8.05 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.1%. This growth during the historical period is a consequence of various factors including more stringent government regulations, escalating environmental concerns, a rising elderly population, the evolution of patient-centered healthcare paradigms, and advancements in healthcare infrastructure.
What's the Projected Size of the Global Artificial Intelligence (AI) In Respiratory Diseases Market by 2029?
The market size for artificial intelligence (AI) in respiratory diseases is likely to witness substantial expansion in the upcoming years, reaching a value of $9.85 billion in 2029, with a compound annual growth rate (CAGR) of 5.2%. The projected growth in the forecast period could be due to the increasing prevalence of respiratory conditions, the pressing need for early detection and diagnosis, escalating environmental pollution, higher healthcare expenditures, and research and development initiatives. Key trends forecasted to have a significant impact during this period include technological advancements, drug discovery and development, customized treatment plans, telemedicine and remote patient monitoring, remote patient monitoring.
View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report
Top Growth Drivers in the Artificial Intelligence (AI) In Respiratory Diseases Industry: What's Accelerating the Market?
The escalating issue of environmental contamination is predicted to fuel the expansion of the artificial intelligence (AI) in the respiratory disease market. Environmental contamination implies the rapid introduction of substances or energy into the environment, faster than its dispersal or safe storage. AI usage in respiratory conditions could notably decrease the influence of environmental pollution on respiratory health by providing real-time observation, personalized evaluations of risk, informed decision-making, and novel solutions tailored to both individual and community needs. For example, data from the US Energy Information Administration, an American government agency, indicated that the CO2 emissions in 2021 were 35.72 billion metric tons which surged to 38.50 billion metric tons in 2022. Hence, the surge in environmental contamination is propelling the expansion of artificial intelligence (AI) in the respiratory disease market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp
What Trends Will Shape the Artificial Intelligence (AI) In Respiratory Diseases Market Through 2029 and Beyond?
Top-tier companies immersed in the field of artificial intelligence (AI) and its application to respiratory illnesses are showing ingenuity by producing cutting-edge devices like N-Tidal, which closely monitor patients' respiration. By measuring the amount of air circulated during standard breathing, the n-Tidal device offers critical insights into lung health. For instance, TidalSense, a respiratory technology firm based in the UK, owned the spotlight in August 2023 when it introduced N-Tidal, a controlled AI technology geared towards graceful diagnosis and management of chronic obstructive pulmonary disease (COPD). This technology merges N-Tidal's CO2 sensor data and an AI platform to gauge alterations in lung functionality with the goal of enhancing the detection and management of this concerning respiratory disorder. Its stellar precision has been confirmed through clinical trials, promising a revolutionary shift in the diagnostic procedures for respiratory diseases. This deubt represents a crucial leap forward in the employment of AI for evaluating respiratory diseases, by presenting a more user-friendly and efficient option compared to existing diagnostic methods.
What Are the Main Segments in the Artificial Intelligence (AI) In Respiratory Diseases Market?
The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented -
1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13792&type=smp
Which Top Companies are Driving Growth in the Artificial Intelligence (AI) In Respiratory Diseases Market?
Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.
Which Regions Will Dominate the Artificial Intelligence (AI) In Respiratory Diseases Market Through 2029?
North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13792
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Intelligence (AI) In Respiratory Diseases Market on Track for Strong Growth, Estimated to Grow at 5.2% CAGR Through 2029 here
News-ID: 4118623 • Views: …
More Releases from The Business Research Company
Impact Of Rising Infrastructure Investment On The Market Growth Due To Increasin …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Hydrophilic Swelling Waterstop Market Through 2025?
In recent times, there has been robust growth in the hydrophilic swelling waterstop market size. It is expected to mature from a value of $0.87 billion in 2024 to $0.94 billion in 2025, illustrating a compound…
Emerging Trends to Drive Hot Melt Waterproofing System Market Growth at 7% CAGR …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Hot Melt Waterproofing System Market Size Growth Forecast: What to Expect by 2025?
There has been a substantial expansion in the hot melt waterproofing system market in the last few years. It is projected to rise from $2.34 billion in 2024 to $2.52 billion in 2025, with a compound…
High-Pressure Blasting Service Market: Major Trends Reshaping the Future of the …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the High-Pressure Blasting Service Industry Market Size Be by 2025?
The market size for high pressure blasting services has seen substantial growth in the past few years. The market, which is predicted to rise from a value of $3.18 billion in 2024 to $3.40 billion in 2025,…
Impact Of Rising Construction Activities On The Market Growth Due To Increasing …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
High Performance Plasterboard Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the last few years, there has been a robust expansion of the high performance plasterboard market size. It's predicted to increase from $13.32 billion in 2024 to $14.21 billion in 2025, showcasing a…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
